Frelinger, Andrew L <br/><br/>
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin.  [electronic resource] 

 -  Thrombosis and haemostasis  Jul 2007 
 - 192-200 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Diphosphate--pharmacology<br/>Adult<br/>Aspirin--pharmacology<br/>Biomarkers--blood<br/>Blood Cells<br/>Calcium--pharmacology<br/>Cells, Cultured<br/>Female<br/>Humans<br/>Inflammation<br/>Kinetics<br/>Male<br/>Middle Aged<br/>Piperazines--pharmacology<br/>Platelet Activation--drug effects<br/>Prasugrel Hydrochloride<br/>Purinergic P2 Receptor Antagonists<br/>Thiophenes<br/>Thrombosis<br/>Up-Regulation